A Phase 1 Open-Label Study to Evaluate the Metabolism and Excretion of CC-223 and the Effect of Food on the Pharmacokinetics of CC-223 in Healthy Male Adult Subjects

Clinical trial NCT01611467 · COMPLETED

Trial details

NCT number: NCT01611467
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety and Pharmacokinetics in Healthy Volunteer Subjects

Start date: 2012-06-01
Primary completion: 2012-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.